Page last updated: 2024-11-07

methylprednisolone acetate and Kaposi Sarcoma

methylprednisolone acetate has been researched along with Kaposi Sarcoma in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Research Excerpts

ExcerptRelevanceReference
"Kaposi's sarcoma has been reported in patients receiving immunosuppressive therapy, most of whom are organ transplant recipients."1.29Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids. ( David, M; Hodak, E; Neeman, A; Sandbank, M; Trattner, A, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trattner, A1
Hodak, E1
David, M1
Neeman, A1
Sandbank, M1

Other Studies

1 other study available for methylprednisolone acetate and Kaposi Sarcoma

ArticleYear
Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids.
    Journal of the American Academy of Dermatology, 1993, Volume: 29, Issue:5 Pt 2

    Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Injection

1993